e-learning
resources
Munich 2006
Tuesday 05.09.2006
Hospital-acquired pneumonia: from inflammation to treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Impact of antibiotic consumption in the evolution of respiratory
pseudomonas
antibiotic resistance
J. Tárrega, C. Marti, M. Sagales, E. Barbeta (Granollers, Spain)
Source:
Annual Congress 2006 - Hospital-acquired pneumonia: from inflammation to treatment
Session:
Hospital-acquired pneumonia: from inflammation to treatment
Session type:
Poster Discussion
Number:
4511
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Tárrega, C. Marti, M. Sagales, E. Barbeta (Granollers, Spain). Impact of antibiotic consumption in the evolution of respiratory
pseudomonas
antibiotic resistance. Eur Respir J 2006; 28: Suppl. 50, 4511
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Biological resistance to beta-lactamic antibiotics in patients with respiratory infection in the prediction of efficiency of antibacterial therapy
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Year: 2020
Epidemiological impact of antibiotic use/misuse in the community
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=165
Year: 2004
Analysis of antibiotic resistance and enterococcal infections of low respiratory infection on patients in hospital
Source: Eur Respir J 2003; 22: Suppl. 45, 450s
Year: 2003
Antibiotic resistance and nosocomial pneumonia
Source: Eur Respir J 2005; 26: Suppl. 49, 641s
Year: 2005
Lower respiratory infection and antimicrobial resistance
Source: International Congress 2018 – New challenges in tackling known diseases with the 10 ERS Principles for Lung Health
Year: 2018
Frequency of side effects in antibiotic treatment for pneumonia
Source: International Congress 2019 – Clinical challenges in respiratory infection
Year: 2019
Bacteriological evidence of antibiotic failure in pneumococcal lower respiratory tract infections
Source: Eur Respir J 2002; 20: 3S-8S
Year: 2002
Chronic use of azithromycin in CF is associated with a substantial increase in macrolide resistance of
S. aureus
and
haemophilus
Source: Annual Congress 2006 - Cystic fibrosis lung disease: molecules images and drugs
Year: 2006
Antibiotic resistance and clinical outcomes: the CAPNETZ experience
Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections
Year: 2006
Antibiotic stewardship in respiratory infections
Source: International Congress 2016 – Respiratory infections in high-income countries: old challenges and new threats
Year: 2016
Antibiotic management and resistance
Source: Eur Respir Monogr 2018; 81: 312-330
Year: 2018
Importance of appropriate initial antibiotic therapy and de-escalation in the treatment of nosocomial pneumonia
Source: Eur Respir Rev 2007; 16: 33-39
Year: 2007
Colistin as a first choice antibiotic for the initial empiric antimicrobial therapy of ventilator-associated pneumonia
Source: Eur Respir J 2007; 30: 1234-1235
Year: 2007
Antibiotic resistance in pulmonary infections: mechanisms and epidemiology
Source: Eur Respir Monogr 2017; 75: 21-43
Year: 2017
Antimicrobial resistance in respiratory diseases
Source: International Congress 2019 – Fighting antimicrobial resistance: from prevention to antimicrobial stewardship
Year: 2019
The effect of addition of macrolide to a beta-lactam antibiotic on treatment success in patients with moderately severe community acquired pneumonia
Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations
Year: 2010
Prevalence and antibiotic susceptibility of pathogens from analysis of respiratory samples
Source: Eur Respir J 2007; 30: Suppl. 51, 405s
Year: 2007
The impact of antibiotic resistance in the management of lower respiratory tract infections
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=131
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept